Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2020Q3 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2020Q2 $ vs. 2020Q2
Mirati Therapeutics, Inc. 3,435,575 $570,477,000 8.33% +664,525 +$254,106,000
Retrophin, Inc. NOTE 2.500% 9/1 45,000,000 $390,119,000 5.70% No Change +$40,140,000
AMICUS THERAPEUTICS, INC. 25,122,048 $354,723,000 5.18% -60,316 -$25,027,000
IOVANCE BIOTHERAPEUTICS, INC. 10,085,632 $332,019,000 4.85% -1,723,862 +$7,849,000
Global Blood Therapeutics, Inc. 5,800,996 $319,867,000 4.67% -41,104 -$48,944,000
BridgeBio Pharma, Inc. 6,706,268 $251,619,000 3.67% No Change +$32,928,000
CYTOKINETICS INC NOTE 4.000%11/1 9,770,000 $218,301,000 3.19% -230,000 -$19,959,000
Zymeworks Inc. 4,400,999 $204,999,000 2.99% +820,000 +$75,833,000
MyoKardia, Inc. 1,395,017 $190,183,000 2.78% No Change +$55,396,000
SpringWorks Therapeutics, Inc. 3,481,148 $165,946,000 2.42% -33,210 +$18,343,000
COLLEGIUM PHARMACEUTICAL, INC NOTE 2.625% 2/1 17,500,000 $163,765,000 2.39% No Change +$6,538,000
Athenex, Inc. 13,532,467 $161,323,000 2.36% +2,000,000 +$5,388,000
VBI Vaccines Inc/BC 55,042,465 $157,421,000 2.30% No Change -$13,210,000
NEUROCRINE BIOSCIENCES INC 1,548,715 $148,924,000 2.17% -592,695 -$112,328,000
OUTSET MED INC 2,847,822 $142,391,000 2.08% New +$142,391,000
NEVRO CORP NOTE 2.750% 4/0 9,000,000 $141,822,000 2.07% No Change +$20,322,000
NEVRO CORP 826,164 $115,085,000 1.68% -73,808 +$7,565,000
CRISPR Therapeutics AG NAMEN AKT 1,341,308 $112,187,000 1.64% New +$112,187,000
RELAY THERAPEUTICS INC 2,329,407 $99,209,000 1.45% New +$99,209,000
MeiraGTx Holdings plc 6,433,277 $85,176,000 1.24% No Change +$4,632,000
Quotient Ltd 16,200,818 $83,272,000 1.22% New +$83,272,000
Alector, Inc. 2,360,139 $78,758,000 1.15% +400,000 +$26,834,000
IMMUNOMEDICS INC 912,140 $77,559,000 1.13% +550,000 +$64,725,000
NOVAVAX INC 707,715 $76,681,000 1.12% +357,715 +$47,508,000
Coherus BioSciences, Inc. 3,636,485 $66,693,000 0.97% +3,091,200 +$56,954,000